Carr Financial Group’s Gilead Sciences GILD Stock Holding History

Carr Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$585K	Buy	4,196 +39	+0.9%	+$5.46K	0.15%	92
2025 Q4	$510K	Buy	4,157 +23	+0.6%	+$2.79K	0.14%	102
2025 Q3	$459K	Sell	4,134 -72	-2%	-$8.18K	0.13%	107
2025 Q2	$466K	Buy	4,206 +28	+0.7%	+$2.98K	0.14%	100
2025 Q1	$468K	Sell	4,178 -1,472	-26%	-$152K	0.15%	94
2024 Q4	$522K	Sell	5,650 -1,939	-26%	-$175K	0.16%	93
2024 Q3	$636K	Buy	7,589 +65	+0.9%	+$4.96K	0.19%	91
2024 Q2	$516K	Buy	7,524 +80	+1%	+$5.34K	0.16%	103
2024 Q1	$545K	Sell	7,444 -195	-3%	-$15K	0.18%	98
2023 Q4	$619K	Buy	7,639 +1	+0%	+$78	0.23%	73
2023 Q3	$623K	Hold	7,638	–	–	0.25%	70
2023 Q2	$589K	Buy	7,638 +73	+1%	+$5.82K	0.24%	76
2023 Q1	$628K	Sell	7,565 -940	-11%	-$77.9K	0.28%	74
2022 Q4	$730K	Buy	+8,505	New	+$674K	0.38%	61

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Carr Financial Group's GILD Position: Q1 2026 in Review

Carr Financial Group increased its Gilead Sciences (GILD) stake by 0.94% in Q1 2026, buying an estimated $5.46K and bringing the position to 4,196 shares worth $585K. The position accounts for 0.15% of the portfolio, ranked #92.

Carr Financial Group first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $730K in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Carr Financial Group held 4,196 shares of Gilead Sciences worth $585K as of Q1 2026.
Carr Financial Group bought 39 Gilead Sciences shares in Q1 2026, an estimated $5.46K.
Gilead Sciences made up 0.15% of Carr Financial Group's portfolio in Q1 2026, its #92 holding.
Carr Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
Carr Financial Group's Gilead Sciences position peaked at $730K in Q4 2022.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Carr Financial Group's 13F filing for Q1 2026, filed 12 May 2026.